BioNTech, Moderna, J&J Explore Omicron Versions of Shots

(Bloomberg) — BioNTech SE, Moderna Inc. and Johnson & Johnson are working to adapt their Covid-19 vaccines to address the omicron variant, with the German partner of Pfizer Inc. saying it could have a new version ready within 100 days if necessary. Read More